CAR-T cell therapy modifies a patient's T-cells to target and destroy cancer cells.

BA have two different binding sites, one for cancer cells and one for immune cells, facilitating a targeted immune attack.

Checkpoint inhibitors block proteins that prevent the immune system from attacking cancer cells.

Personalized vaccines targeting unique mutations in a patient's tumor to stimulate a robust immune response.

Involves extracting, expanding, and reinfusing lymphocytes that have penetrated a tumor to boost the immune response.

Uses genetically modified viruses to selectively infect and kill cancer cells while stimulating an anti-tumor immune response.

Harnesses and enhances NK cells' natural ability to attack cancer cells without prior sensitization.

Uses synthetic RNA molecules to interfere with gene expression involved in cancer development.